629 related articles for article (PubMed ID: 21692821)
21. Inflammatory bowel disease as a risk factor for colorectal cancer.
Lukas M
Dig Dis; 2010; 28(4-5):619-24. PubMed ID: 21088413
[TBL] [Abstract][Full Text] [Related]
22. Primary sclerosing cholangitis associated with inflammatory bowel disease: an update.
Rossi RE; Conte D; Massironi S
Eur J Gastroenterol Hepatol; 2016 Feb; 28(2):123-31. PubMed ID: 26636407
[TBL] [Abstract][Full Text] [Related]
23. Primary sclerosing cholangitis and disease distribution in inflammatory bowel disease.
O'Toole A; Alakkari A; Keegan D; Doherty G; Mulcahy H; O'Donoghue D
Clin Gastroenterol Hepatol; 2012 Apr; 10(4):439-41. PubMed ID: 22094024
[TBL] [Abstract][Full Text] [Related]
24. PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis.
Loftus EV; Harewood GC; Loftus CG; Tremaine WJ; Harmsen WS; Zinsmeister AR; Jewell DA; Sandborn WJ
Gut; 2005 Jan; 54(1):91-6. PubMed ID: 15591511
[TBL] [Abstract][Full Text] [Related]
25. Relationship of inflammatory bowel disease and primary sclerosing cholangitis.
Fausa O; Schrumpf E; Elgjo K
Semin Liver Dis; 1991 Feb; 11(1):31-9. PubMed ID: 2047887
[TBL] [Abstract][Full Text] [Related]
26. Effect of ursodeoxycholic acid use on the risk of colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease: a systematic review and meta-analysis.
Singh S; Khanna S; Pardi DS; Loftus EV; Talwalkar JA
Inflamm Bowel Dis; 2013 Jul; 19(8):1631-8. PubMed ID: 23665966
[TBL] [Abstract][Full Text] [Related]
27. [Risk factors for ulcerative colitis associated colorectal cancers in a Hungarian cohort of ulcerative colitis patients].
Lakatos L; Mester G; Erdélyi Z; David G; Pandúr T; Balogh M; Fischer S; Vargha P; Lakatos PL
Orv Hetil; 2006 Jan; 147(4):175-81. PubMed ID: 16515026
[TBL] [Abstract][Full Text] [Related]
28. [Inflammatory bowel disease and colorectal cancer].
Hagymási K; Tulassay Z
Orv Hetil; 2006 Oct; 147(41):1977-82. PubMed ID: 17120688
[TBL] [Abstract][Full Text] [Related]
29. Genetic polymorphisms associated with inflammatory bowel disease do not confer risk for primary sclerosing cholangitis.
Karlsen TH; Hampe J; Wiencke K; Schrumpf E; Thorsby E; Lie BA; Broomé U; Schreiber S; Boberg KM
Am J Gastroenterol; 2007 Jan; 102(1):115-21. PubMed ID: 17100974
[TBL] [Abstract][Full Text] [Related]
30. Colorectal cancer and cholangiocarcinoma in patients with primary sclerosing cholangitis and inflammatory bowel disease.
Manninen P; Karvonen AL; Laukkarinen J; Aitola P; Huhtala H; Collin P
Scand J Gastroenterol; 2015 Apr; 50(4):423-8. PubMed ID: 25636976
[TBL] [Abstract][Full Text] [Related]
31. Colorectal cancer after orthotopic liver transplantation.
Silva MA; Jambulingam PS; Mirza DF
Crit Rev Oncol Hematol; 2005 Oct; 56(1):147-53. PubMed ID: 16140543
[TBL] [Abstract][Full Text] [Related]
32. Inflammatory bowel disease is associated with poor outcomes of patients with primary sclerosing cholangitis.
Ngu JH; Gearry RB; Wright AJ; Stedman CA
Clin Gastroenterol Hepatol; 2011 Dec; 9(12):1092-7; quiz e135. PubMed ID: 21893134
[TBL] [Abstract][Full Text] [Related]
33. In PSC with dominant bile duct stenosis, IBD is associated with an increase of carcinomas and reduced survival.
Rudolph G; Gotthardt D; Kloeters-Plachky P; Rost D; Kulaksiz H; Stiehl A
J Hepatol; 2010 Aug; 53(2):313-7. PubMed ID: 20472317
[TBL] [Abstract][Full Text] [Related]
34. Liver transplantation for primary sclerosing cholangitis: timing, outcome, impact of inflammatory bowel disease and recurrence of disease.
Wiesner RH
Best Pract Res Clin Gastroenterol; 2001 Aug; 15(4):667-80. PubMed ID: 11492975
[TBL] [Abstract][Full Text] [Related]
35. Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis.
Boonstra K; Weersma RK; van Erpecum KJ; Rauws EA; Spanier BW; Poen AC; van Nieuwkerk KM; Drenth JP; Witteman BJ; Tuynman HA; Naber AH; Kingma PJ; van Buuren HR; van Hoek B; Vleggaar FP; van Geloven N; Beuers U; Ponsioen CY;
Hepatology; 2013 Dec; 58(6):2045-55. PubMed ID: 23775876
[TBL] [Abstract][Full Text] [Related]
36. Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies.
Triantafillidis JK; Nasioulas G; Kosmidis PA
Anticancer Res; 2009 Jul; 29(7):2727-37. PubMed ID: 19596953
[TBL] [Abstract][Full Text] [Related]
37. Risk factors for colorectal neoplasia in inflammatory bowel disease: a nested case-control study from Copenhagen county, Denmark and Olmsted county, Minnesota.
Jess T; Loftus EV; Velayos FS; Winther KV; Tremaine WJ; Zinsmeister AR; Scott Harmsen W; Langholz E; Binder V; Munkholm P; Sandborn WJ
Am J Gastroenterol; 2007 Apr; 102(4):829-36. PubMed ID: 17222314
[TBL] [Abstract][Full Text] [Related]
38. Reviewing the Risk of Colorectal Cancer in Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis.
Rao BB; Lashner B; Kowdley KV
Inflamm Bowel Dis; 2018 Jan; 24(2):269-276. PubMed ID: 29361103
[TBL] [Abstract][Full Text] [Related]
39. Colorectal neoplasia in PSC-IBD patients: are times changing?
Sokol H; Chazouilleres O
Liver Int; 2012 Feb; 32(2):175-6. PubMed ID: 22226230
[No Abstract] [Full Text] [Related]
40. Primary sclerosing cholangitis as an independent risk factor for colorectal cancer in the context of inflammatory bowel disease: a review of the literature.
Wang R; Leong RW
World J Gastroenterol; 2014 Jul; 20(27):8783-9. PubMed ID: 25083052
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
